BMS345541 hydrochloride
(Synonyms: N-(1,8-二甲基咪唑并[1,2-A]喹喔啉-4-基)-1,2-乙二胺盐酸盐,BMS-345541 hydrochloride;BMS 345541 hydrochloride) 目录号 : GC12399A selective inhibitor of IKKα and IKKβ
Cas No.:547757-23-3
Sample solution is provided at 25 µL, 10mM.
BMS-345541 is a highly selective inhibitor of IKK-1 and IKK-2 with IC50 values of 4μM and 0.3μM, respectively [1].
BMS-345541 is a highly selective inhibitor of IKK that inhibits NF-κB-dependent transcription of pro-inflammatory cytokines both in vitro and in vivo. This specificity is proved in the assay measuring the IKK-2-catalyzed phosphorylation of GST-IκB. In this assay, BMS-345541 fails to inhibit other serine/threonine and tyrosine kinases. This selectivity is also evident in cells, only the stimulus-induced phosphorylation of IκB was inhibited by BMS-345541 whereas other signal transduction cascades were unaffected [1].
Since the IKK/ NFκB pathway is important for viability of leukemic cells and is a predictor of relapse in T-ALL, BMS-345541 is tested in some T-ALL cell lines. It is found that BMS-345541 can induce apoptosis and an accumulation of cells in the G2/M phase of the cell cycle. BMS-345541 can be used in combination with traditional therapies to overcome resistance to chemotherapeutic agents [2].
References:
[1] James R. Burke, Mark A. Pattoli, Kurt R. Gregor, Patrick J. Brassil, John F. MacMaster, Kim W. McIntyre, Xiaoxia Yang, Violetta S. Iotzova, Wendy Clarke, Joann Strnad, Yuping Qiu and F. Christopher Zusi. BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice. J. Biol. Chem. 2003, 278:1450-1456.
[2] Francesca Buontempo, Francesca Chiarini, Daniela Bressanin, Giovanna tabellini, Fraia Melchionda, Andrea pession, Milena Fini, Luca M. Neri, James A. McCubrey and Alberto M. Martelli. Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia. Cell Cycle. 2012, 11 (13): 2467-2475.
Kinase experiment [1]: | |
Enzyme Assays |
Assays measuring the enzyme-catalyzed phosphorylation of GST-IκBα were performed by adding enzyme (IKK-2, IKK-1 or IKK-ε, typically to a final concentration of 0.5 μg/mL) at 30℃ to solutions of 100 μg/mL GST- IκBα and 5 μM [33P]ATP in 40 mM Tris HCl, pH 7.5, containing 4 mM MgCl2, 34 mM sodium phosphate, 3 mM NaCl, 0.6 mM potassium phosphate, 1 mM KCl, 1 mM dithiothreitol, 3% (w/v) glycerol, and 250 μg/mL bovine serum albumin. The specific activity of [33P]ATP used in the assay was 100 Ci/mmol. After 5 mins, the kinase reactions were stopped by the addition of 2× Laemmli sample buffer and heat-treated at 90℃ for 1 min. The samples were then loaded on to NuPAGE 10% BisTris gels. After completion of SDS-PAGE, gels were dried on a slab gel dryer. The bands were then detected using a 445Si PhosphorImager, and the radioactivity was quantified using ImageQuant software. Under these conditions, the degree of phosphorylation of GST-IκBα was linear with time and concentration of enzyme. |
Cell experiment [1]: | |
Cell lines |
THP-1 monocytic cells |
Preparation method |
Soluble in DMSO. General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months. |
Reaction Conditions |
1 ~ 100 μM or 0.04 ~ 25 μM; 60 mins |
Applications |
BMS-345541 inhibited the TNFα-stimulated phosphorylation of Iκ-Bα in a dose-dependent manner (IC50 = 4 μM), and reduced the stimulated production of TNFα, IL-1β, IL-8 and IL-6 (IC50 = 1 ~ 5 μM). |
Animal experiment [1]: | |
Animal models |
Female BALB/c mice |
Dosage form |
2 mg/kg (1 mL/kg), i.v.; 10 mg/kg (5 mL/kg), p.o. |
Applications |
Oral administration of BMS-345541 to mice resulted in prolonged serum drug levels, with concentrations sustained at or above 1 μM for many hrs. BMS-345541 exhibited 100% oral bioavailability. At the dose of 10 mg/kg, BMS-345541 inhibited the production of TNFα induced by LPS and exhibited 50% inhibition. At the dose of 100 mg/kg, BMS-345541 completely inhibited TNFα production. |
Other notes |
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
References: [1]. Burke JR, Pattoli MA, Gregor KR, et al. BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem, 2003, 278(3): 1450-1456. |
Cas No. | 547757-23-3 | SDF | |
别名 | N-(1,8-二甲基咪唑并[1,2-A]喹喔啉-4-基)-1,2-乙二胺盐酸盐,BMS-345541 hydrochloride;BMS 345541 hydrochloride | ||
化学名 | N'-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine;hydrochloride | ||
Canonical SMILES | CC1=CC2=C(C=C1)N=C(C3=NC=C(N23)C)NCCN.Cl | ||
分子式 | C14H18ClN5 | 分子量 | 291.78 |
溶解度 | ≥ 60 mg/mL in Water | 储存条件 | Store at 2-8°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.4272 mL | 17.1362 mL | 34.2724 mL |
5 mM | 0.6854 mL | 3.4272 mL | 6.8545 mL |
10 mM | 0.3427 mL | 1.7136 mL | 3.4272 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet